<?xml version="1.0" encoding="UTF-8"?><!--Transformation version 1.3--><legislativeDoc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.lexisnexis.com/xmlschemas/content/public/legislativedoc/1/" schemaVersion="1.0"><legislativeDocHead><citations><citeForThisResource citeDefinition="#7159#349#000054#     1#         3222#">Va. Code Ann. § 54.1-3222</citeForThisResource></citations><legislativeBodyInfo><jurisdiction><jurisSystem normalizedLongName="Virginia" normalizedShortName="VA"/></jurisdiction></legislativeBodyInfo></legislativeDocHead><legislativeDocBody><statute><level levelType="section"><anchor id="_54.1-3222"/><heading><desig>§ 54.1-3222.</desig><title>TPA certification; certification for treatment of diseases or abnormal conditions with therapeutic pharmaceutical agents (TPAs)</title></heading><level levelType="paragraph"><anchor id="_a"/><heading><desig>A.</desig></heading><bodyText><p> The Board shall certify an optometrist to prescribe for and treat diseases or abnormal conditions of the human eye and its adnexa with therapeutic pharmaceutical agents (TPAs), if the optometrist files a written application, accompanied by the fee required by the Board and satisfactory proof that the applicant:</p></bodyText><level levelType="paragraph"><anchor id="_a_1"/><heading><desig>1.</desig></heading><bodyText><p> Is licensed by the Board as an optometrist and certified to administer diagnostic pharmaceutical agents pursuant to Article 4 (<citation type="statute" normalizedCite="VACODE 54.1-3220"><content><span normalizedCite="Va. Code Ann. § 54.1-3220">§ 54.1-3220<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3220#"/></locatorKey></locator></span></content></citation> et seq.);</p></bodyText></level><level levelType="paragraph"><anchor id="_a_2"/><heading><desig>2.</desig></heading><bodyText><p> Has satisfactorily completed such didactic and clinical training programs for the treatment of diseases and abnormal conditions of the eye and its adnexa as are determined, after consultation with a school or college of optometry and a school of medicine, to be reasonable and necessary by the Board to ensure an appropriate standard of medical care for patients; and</p></bodyText></level><level levelType="paragraph"><anchor id="_a_3"/><heading><desig>3.</desig></heading><bodyText><p> Passes such examinations as are determined to be reasonable and necessary by the Board to ensure an appropriate standard of medical care for patients.</p></bodyText></level></level><level levelType="paragraph"><anchor id="_b"/><heading><desig>B.</desig></heading><bodyText><p> TPA certification shall enable an optometrist to prescribe and administer, within his scope of practice, Schedule II controlled substances consisting of hydrocodone in combination with acetaminophen and Schedules III through VI controlled substances and devices as set forth in the Drug Control Act (<citation type="statute" normalizedCite="VACODE 54.1-3400"><content><span normalizedCite="Va. Code Ann. § 54.1-3400">§ 54.1-3400<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3400#"/></locatorKey></locator></span></content></citation> et seq.) to treat diseases and abnormal conditions of the human eye and its adnexa as determined by the Board, within the following conditions:</p></bodyText><level levelType="paragraph"><anchor id="_b_1"/><heading><desig>1.</desig></heading><bodyText><p> Treatment with oral therapeutic pharmaceutical agents shall be limited to (i) analgesics included on Schedule II controlled substances as defined in <citation type="statute" normalizedCite="VACODE 54.1-3448"><content><span normalizedCite="Va. Code Ann. § 54.1-3448">§ 54.1-3448<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3448#"/></locatorKey></locator></span></content></citation> of the Drug Control Act (<citation type="statute" normalizedCite="VACODE 54.1-3400"><content><span normalizedCite="Va. Code Ann. § 54.1-3400">§ 54.1-3400<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3400#"/></locatorKey></locator></span></content></citation> et seq.) consisting of hydrocodone in combination with acetaminophen, and analgesics included on Schedules III through VI, as defined in <citation type="statute" normalizedCite="VACODE 54.1-3450"><content><span normalizedCite="Va. Code Ann. § 54.1-3450">§§ 54.1-3450<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3450#"/></locatorKey></locator></span></content></citation> and <citation type="statute" normalizedCite="VACODE 54.1-3455"><content><span normalizedCite="Va. Code Ann. § 54.1-3455">54.1-3455<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3455#"/></locatorKey></locator></span></content></citation> of the Drug Control Act, which are appropriate to alleviate ocular pain and (ii) other Schedule VI controlled substances as defined in <citation type="statute" normalizedCite="VACODE 54.1-3455"><content><span normalizedCite="Va. Code Ann. § 54.1-3455">§ 54.1-3455<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3455#"/></locatorKey></locator></span></content></citation> of the Drug Control Act appropriate to treat diseases and abnormal conditions of the human eye and its adnexa.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_2"/><heading><desig>2.</desig></heading><bodyText><p> Therapeutic pharmaceutical agents shall include topically applied Schedule VI drugs as defined in <citation type="statute" normalizedCite="VACODE 54.1-3455"><content><span normalizedCite="Va. Code Ann. § 54.1-3455">§ 54.1-3455<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3455#"/></locatorKey></locator></span></content></citation> of the Drug Control Act (<citation type="statute" normalizedCite="VACODE 54.1-3400"><content><span normalizedCite="Va. Code Ann. § 54.1-3400">§ 54.1-3400<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000054#     1#         3400#"/></locatorKey></locator></span></content></citation> et seq.).</p></bodyText></level><level levelType="paragraph"><anchor id="_b_3"/><heading><desig>3.</desig></heading><bodyText><p> Treatment of angle closure glaucoma shall be limited to initiation of immediate emergency care.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_4"/><heading><desig>4.</desig></heading><bodyText><p> Treatment of infantile or congenital glaucoma shall be prohibited.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_5"/><heading><desig>5.</desig></heading><bodyText><p> Treatment through surgery or other invasive modalities shall not be permitted, except for treatment of emergency cases of anaphylactic shock with intramuscular epinephrine.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_6"/><heading><desig>6.</desig></heading><bodyText><p> Entities permitted or licensed by the Board of Pharmacy to distribute or dispense drugs, including, but not limited to, wholesale distributors and pharmacists, shall be authorized to supply TPA-certified optometrists with those therapeutic pharmaceutical agents specified by the Board on the TPA-Formulary.</p></bodyText></level></level><history><historyGroup groupType="history-citation"><historyItem><bodyText><p><citation normalizedCite="1996 VA CH 152"><content><span normalizedCite="1996 Va. Ch. 152">1996, cc. 152<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#1996#000152#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="1996 VA CH 158"><content><span normalizedCite="1996 Va. Ch. 158">158<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#1996#000158#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2004 VA CH 744"><content><span normalizedCite="2004 Va. Ch. 744">2004, c. 744<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2004#000744#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2015 VA CH 355"><content><span normalizedCite="2015 Va. Ch. 355">2015, c. 355<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2015#000355#"/></locatorKey></locator></span></content></citation>.</p></bodyText></historyItem></historyGroup></history></level></statute></legislativeDocBody><metadata><dc:metadata xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:identifier identifierScheme="PGUID">urn:contentItem:5K0Y-PV20-004G-K1V9-00000-00</dc:identifier><dc:source sourceScheme="productContentSetIdentifier">10816</dc:source><dc:date dateType="last-updated">2016-06-15</dc:date></dc:metadata><publicationInfo><publicationName>CODE OF VIRGINIA </publicationName><copyright>Copyright © 2016  by Matthew Bender &amp; Company, Inc. a member of the LexisNexis Group. All rights reserved</copyright></publicationInfo><hierarchy><hierarchyLevel levelType="title"><heading><desig>TITLE 54.1.</desig><title>PROFESSIONS AND OCCUPATIONS</title></heading><hierarchyLevel levelType="subtitle"><heading><desig>SUBTITLE III.</desig><title>PROFESSIONS AND OCCUPATIONS REGULATED BY BOARDS WITHIN THE DEPARTMENT OF HEALTH PROFESSIONS</title></heading><hierarchyLevel levelType="chapter"><heading><desig>CHAPTER 32.</desig><title>OPTOMETRY</title></heading><hierarchyLevel levelType="article"><heading><desig>ARTICLE 5.</desig><title>CERTIFICATION FOR ADMINISTRATION OF THERAPEUTIC PHARMACEUTICAL AGENTS (TPAS).</title></heading></hierarchyLevel></hierarchyLevel></hierarchyLevel></hierarchyLevel></hierarchy><classification classificationScheme="legal"><classificationItem><className>Criminal Law &amp; Procedure</className><classCode>Z3VpZD11cm46dG9waWM6NEU0RkE1OUQwNUQwNDgxODhEODZCMjkzOTg3NThBNzk7cGFyZW50Z3VpZD0</classCode><classificationItem><className>Definitions</className><classCode>Z3VpZD11cm46dG9waWM6NjgxNTc0NUJENzUxNDFCOEI1NzU1RDE1Q0NBOTYzMEE7cGFyZW50Z3VpZD11cm46dG9waWM6REE5OEU0MDg1QjVGNDNDMDk4NDQ1M0M3QzFDRTg4QjA</classCode></classificationItem><classificationItem><className>Opiates</className><classCode>Z3VpZD11cm46dG9waWM6MjJBN0E1NjZBN0Q0NDYzQkJBQTlBOTMyNzNBNzZERDE7cGFyZW50Z3VpZD11cm46dG9waWM6QzFGQ0JDRjQ1RTA3NEJFOEI3QkVEREEyRDlFNTVBRDg</classCode></classificationItem></classificationItem></classification><classificationGroup classificationScheme="indexing-terms"><classification classificationScheme="legal"><classificationItem><className>Business &amp; Corporate Compliance</className><classCode>Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI7cGFyZW50Z3VpZD0</classCode><classificationItem score="90"><className>Businesses &amp; Corporations</className><classCode>Z3VpZD11cm46dG9waWM6QjA4OEVGODBENzY4NDcxM0IyQzA1OTEwQzVDODRBOUE7cGFyZW50Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI</classCode></classificationItem></classificationItem></classification></classificationGroup></metadata></legislativeDoc>